Back to Search
Start Over
Advances in the applications of polymer biomaterials for in vitro follicle culture
- Source :
- Biomedicine & Pharmacotherapy, Vol 140, Iss, Pp 111422-(2021)
- Publication Year :
- 2020
-
Abstract
- The ovarian reserve (OR) indicates ovarian function by representing the quantity and quality of ovarian follicles, and it gradually decreases with increasing age. With the prolongation of women’s lives, the protection provided by estrogen is lost for decades in postmenopausal women, and the related cardiovascular and cerebrovascular diseases, osteoporosis, and decreased immunity are the main risk factors affecting women’s quality of life and longevity. Pharmacologic hormone replacement therapy (PHRT) has been controversial, and the construction of artificial ovary (AO) has attracted increasing attention. The most critical step of AO generation is the establishment of an in vitro culture (IVC) system to support the development of isolated follicles. This article mainly compares the advantages and disadvantages of different polymer biomaterials for use in follicle IVC, provides theoretical support for the development and construction of the follicle IVC system using natural biological materials, and provides a theoretical basis for establishing mature AO technology.
- Subjects :
- Follicle
0301 basic medicine
medicine.drug_class
Polymers
medicine.medical_treatment
Osteoporosis
Ovary
Biocompatible Materials
RM1-950
Bioinformatics
Biomaterials
Tissue Culture Techniques
03 medical and health sciences
0302 clinical medicine
Ovarian Follicle
medicine
Animals
Humans
Ovarian reserve
Pharmacology
Artificial ovary
business.industry
Hormone replacement therapy (menopause)
In vitro culture
General Medicine
medicine.disease
Biological materials
In vitro
030104 developmental biology
medicine.anatomical_structure
Estrogen
030220 oncology & carcinogenesis
Quality of Life
Female
Therapeutics. Pharmacology
business
Subjects
Details
- ISSN :
- 19506007
- Volume :
- 140
- Database :
- OpenAIRE
- Journal :
- Biomedicinepharmacotherapy = Biomedecinepharmacotherapie
- Accession number :
- edsair.doi.dedup.....a1adcc321608182b189768506bd82c82